Silas Deane elected to the Board of Directors at AIM-HI Accelerator Fund
Silas Deane is the Vice President of Courts and Justice at Tyler Technologies. He is on the Board of Directors at AIM-HI Accelerator Fund and an Executive Board Member at the Nashville Technology Council. He was also the CEO of VendEngine and DEANE | SMITH. He earned his BS degree from the
University of Kentucky. He completed his masters from The University of Pennsylvania and The Johns Hopkins University. He has also been the Executive Director at the International Microelectronics Society. Additionally he has been the Legislative Advisor and Press Secretary at the U.S. House of Representatives and the Advance Director for the U.S. Bill of Rights – 200th Anniversary Tour.
In 2011, Silas Deane founded VendEngine, Inc., a company that revolutionized public safety systems by providing real-time data and transparency while supporting incarcerated individuals and their families. The company was acquired by Tyler Technologies in 2021 for $84 million, where Silas Deane now serves as Vice President, focusing on driving innovation and growth in public safety technology.
Recognized by Deloitte and Touche in 2020 as one of North America’s Top 300 Fastest Growing Technology Companies, Mr. Deane’s entrepreneurial achievements will now fuel AIM-HI’s mission to foster innovation in oncology startups and help bring cancer treatments from lab to clinic.
AIM-HI Accelerator Fund shared on LinkedIn:
“The AIM-HI Accelerator Fund welcomes Mr. Silas Deane, Vice President at Tyler Technologies, to our Board of Directors. Mr. Deane, a long-time supporter and advocate of innovative cancer research, brings a wealth of expertise in technology, healthcare, and business development. His leadership and entrepreneurial background mark a significant addition to AIM-HI’s mission of advancing oncology-focused startups and accelerating breakthroughs in cancer treatments.”
‘As cancer research advances, it’s becoming clear that innovation and early-stage investment are crucial to achieving real breakthroughs. I’m honored to join AIM-HI’s Board and excited to contribute to their efforts in supporting pioneering companies that are poised to make a real difference in cancer treatment.’ – Silas Deane, Vice President at Tyler Technologies
“Silas’s track record of driving technology and business innovation makes him a perfect fit for our Board. We’re looking forward to working together to propel our mission of accelerating promising cancer treatments and providing vital support to oncology startups. – Dr. Sujuan Ba, CEO and Co-Founder of AIM-HI.
Read More.
Support Our Mission.
The AIM-HI Accelerator Fund (AIM-HI) is an independent 501 (C) (3) non-profit organization created in 2019 by the National Foundation for Cancer Research to provide oncology startups with the resources they need to drive innovative discoveries forward, out of the lab, to the clinics, and eventually to the people battling cancer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023